IDO1 and neoplasm: Alterations in glycolysis and lactate accumulation, lipid metabolic rewiring, metal-dependent cell death pathways such as ferroptosis and cuproptosis, and the tryptophan–IDO1–kynurenine axis collectively contribute to an immunosuppressive niche that drives tumor progression and therapeutic resistance.